Bioharvest Sciences Cash Flow Statement (2023-2025) | BHST

Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) 2.85M1.73M7.24M6.58M0.69M2.69M7.24M2.34M4.08M2.51M-2.05M
Share-based Compensation (Quarter) 0.13M0.20M0.13M0.15M0.13M0.18M0.13M0.15M
Gains from Equity Investments (Quarter) 4.62M-1.17M0.03M0.02M
Gains from Investment Securities (Quarter) -0.37M2.95M0.41M-0.37M3.45M
Non-cash Items (Quarter) 2.08M2.36M
Cash from Operations (Quarter) -0.99M-2.99M-1.58M-0.96M-1.76M-2.39M-1.43M-1.46M-2.09M-2.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.22M0.22M0.20M0.36M0.35M0.34M0.40M0.41M0.39M0.43M
Change in Working Capital
Change in Receivables (Quarter) 0.04M0.03M-0.27M0.07M-0.25M0.75M-0.06M-0.10M-0.20M1.23M
Change in Inventory (Quarter) -0.08M-0.39M-0.21M0.11M-0.62M1.91M-0.36M-0.12M-0.31M1.68M
Change in Accured Expenses (Quarter) 0.82M-0.12M-0.13M0.37M1.10M-0.30M0.56M0.84M0.06M-0.98M
Change in Taxes (Quarter) 0.01M
Other Working Capital Changes (Quarter) 0.06M0.22M-0.14M-0.55M
Investing Activities
Capital Expenditures (Quarter) -0.44M-0.29M-0.22M-1.71M-0.51M5.28M-0.68M-0.59M-0.42M4.06M
Cash from Investing Activities (Quarter) -0.44M-0.29M-0.22M-1.93M-0.47M-0.40M-0.68M-0.59M-0.42M-0.67M
Financing Activities
Other financing activities (Quarter) -0.41M0.41M-1.36M
Cash from Financing Activities (Quarter) 1.18M7.01M-0.12M4.61M-0.16M2.45M3.12M2.39M9.74M14.94M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) -4.33M
Additional items
Exchange Rate Effect (Quarter) -0.00M0.07M-0.00M0.02M-0.01M-0.04M-0.00M-0.01M0.02M
Change in Cash (Quarter) -0.25M3.72M-1.92M1.72M-2.40M-0.34M1.01M0.34M7.22M-8.53M
Free Cash Flow (Quarter) -0.56M-2.70M-1.36M0.75M-1.25M-7.67M-0.74M-0.86M-1.67M-6.31M
Net Cash Flow (Quarter) -0.25M3.72M-1.92M1.72M-2.40M-0.34M1.01M0.34M7.22M12.02M